Zaloguj Zarejestruj się zadarmo

Ayala Pharmaceuticals organizacji Forward P/E

Jaka jest wartość Forward P/E organizacji Ayala Pharmaceuticals?

Wartość Forward P/E organizacji Ayala Pharmaceuticals Inc. to -0.14

Jaka jest definicja Forward P/E?



Wskaźnik ceny do zysku to stosunek ceny akcji spółki do szacunkowego zysku spółki na akcję za następne dwanaście miesięcy.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Forward P/E firm w Health Care sektor na NASDAQ w porównaniu do Ayala Pharmaceuticals

Czym się zajmuję organizacja Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Firmy z forward p/e podobne do Ayala Pharmaceuticals